TITLE

The Effect of Verapamil on the Lower Esophageal Sphincter Pressure in Normal Subjects and in Achalasia

AUTHOR(S)
Becker, Bruce S.; Burakoff, Robert
PUB. DATE
December 1983
SOURCE
American Journal of Gastroenterology;Dec1983, Vol. 78 Issue 12, p773
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Verapamil hydrochloride is an organic calcium antagonist that is known to decrease the contraction of smooth muscle. The purpose of our study was to determine if verapamil has a similar effect on the resting lower esophageal sphincter pressure in normal subjects and in patients with achalasia. Esophageal manometry was performed using a continuously perfused catheter assembly. Infusion of verapamil (0.15 mg/kg) over a 2-min period resulted in a statistically significant decrease in resting lower esophageal sphincter pressure in both normal subjects (n = 8) and patients with achalasia (n = 7) within 10 min postinfusion. This study suggests that verapamil may have potential as a drug therapy in treating the clinical symptoms of achalasia and diffuse esophageal spasm.
ACCESSION #
16331279

 

Related Articles

  • Hypertension.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS39 

    Presents an abstract of the research manuscript `Design and objectives of the CONVINCE trial,' by L. Poirier, Y. Lacourciere and H.R. Black. Calcium antagonists as treatment of cardiovascular disease; Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE).

  • PII-17. Jin, Y.; Wang, Y.; Hamman, M. A.; Marunde, R.; Hu, Z.; Hilligoss, J.; Hall, S. D. // Clinical Pharmacology & Therapeutics;Feb2006, Vol. 79 Issue 2, pP40 

    Background/aims: Verapamil, a CYP3A4 substrate and inhibitor in vivo, is a more potent mechanistic inhibitor of CYP3A4 than CYP3A5 in vitro. We hypothesized that the clearance of verapamil would be different in subjects genetically capable of expressing CYP3A5 compared to non-expressers.Methods:...

  • Post-Tachycardia T-Wave Syndrome. Katz, Arnold M. // New England Journal of Medicine;1/19/95, Vol. 332 Issue 3, p161 

    his article discusses serial electrocardiograms gathered from a 67-year-old man, which showed no abnormalities. The cardiogram was conducted on a man who was taking digoxin for paroxysmal supraventricular tachycardia. In weeks to come, while undergoing surgery preparations for peripheral...

  • Comparative release profile of sustained release matrix tablets of verapamil HCI. Mathur, Vikas; Nagpal, Kalpana; Singh, Shailendra Kumar; Mishra, Dina Nath // International Journal of Pharmaceutical Investigation;Jan-Mar2013, Vol. 3 Issue 1, p60 

    Introduction: Verapamil hydrochloride (VH) is a calcium channel blocking agent used in the treatment of hypertension, cardiac arrhythmia and angina pectoris. The short half-life and high frequency of administration of VH makes it a suitable candidate for designing sustained drug delivery system....

  • PII-19*. Beitelshees, A. L.; Gong, Y.; Cooper-DeHoff, R. M.; Burt, L.; Stauffer, L. A.; Pepine, C. J.; Johnson, J. A. // Clinical Pharmacology & Therapeutics;Feb2006, Vol. 79 Issue 2, pP41 

    Background: Glu65Lys in KCNMB1 has been found to have functional and clinical significance. We tested whether Glu65Lys or Val110Leu were associated with cardiovascular (CV) outcomes (death, nonfatal myocardial infarction (MI) or nonfatal stroke) in a substudy of INVEST.Methods: INVEST studied...

  • Study on Neuromuscular Blockade Action of Verapamil in Albino Rats. NAGARAL, JAYASHREE; SHASHIKALA, G. H.; JAGADEESH, K.; SHARATH KUMAR, K.; JAYANTH, G. S.; CHENNAVEERAPPA, P. K.; PATIL, RAJANI // Journal of Clinical & Diagnostic Research;Aug2013, Vol. 7 Issue 8, p1617 

    Background: Calcium Channel Blockers (CCBs) are now widely employed in the treatment of cardiovascular diseases and peri-operative hypertension. It has been reported that calcium channel blockers inhibit neuromuscular transmission. They have been shown to increase the neuromuscular blockade...

  • Higher-strength sustained-release calcium antagonist for hypertension.  // Modern Medicine;Jul96, Vol. 64 Issue 7, p38 

    Reports that a higher strength sustained release calcium antagonist called verapamil hydrochloric acid has been approved for marketing.

  • Diltiazem/verapamil overdose.  // Reactions Weekly;4/24/2010, Issue 1298, p15 

    The article describes the case of two men who experienced hypotension and cardiac conduction disorders after attempting suicide by overdose with either dilitiazem and verapamil.

  • PI-22. Langaee, T. Y.; Yarandi, H. N.; Katz, D. A.; Dehoff, R. M.; Kehoe, J. M.; Klocman, A. S.; Pepine, C. J.; Johnson, J. A. // Clinical Pharmacology & Therapeutics;Feb2006, Vol. 79 Issue 2, pP12 

    Background/aims: In the CYP3A5 gene, the A>G (*3) and G>A (*6) SNPs result in splicing defects and severely decreased expression of CYP3A5 enzyme. We tested whether these polymorphisms are associated with differences in response to verapamil, a calcium channel blocker that is a CYP3A substrate...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics